ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000558.1|Sublancin_1 # 47 # 358 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=AGGAG(G)/GGAGG;rbs_spacer=13-15bp;gc_cont=0.327	BGC0000558.1|Sublancin_1 	47	358	-	Loose	175	24.2534	FosG	38.89	3007368	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGAAGAAGAGGCTAATCGGATTTTTGGTCTTAGTTCCTGCTTTGATTATGTCAGGTATTACTTTAATCGAAGCAAATAAAAAGTCCCCTTTGGAAGTAATTGATAATATTCGGGATGAATTTGGTATATTCAGTGTGCAAATTGGTCAAACAGATCCGGCAATTACAATTGGCATGGATCAAACCAAAAGTGAAGCAAAGCTCCGTGAGTATTTAAAAGATAATCTGTCTAGAGAAGCAAAGGAAAAATATAAGATCTATATATTAAAAGATGATATTAATAAATTGGAGAAAGAACATCGAGGTATTTGA	MKKRLIGFLVLVPALIMSGITLIEANKKSPLEVIDNIRDEFGIFSVQIGQTDPAITIGMDQTKSEAKLREYLKDNLSREAKEKYKIYILKDDINKLEKEHRGI	MLRGLNHITIAVSDLGRSLAFYTDIVGMLAHVRWDNGAYLSLGGVWFCLSCDKVMPSKDYSHIALDISEDDFASFLEKLRRADVTEWKQNSSEGYSVYFLDPDGNKLEAHSGSLQSRLSSLKDKPYPGLVWL	78.03	gnl|BL_ORD_ID|4903|hsp_num:0	5896			231	336	fosfomycin
BGC0000558.1|Sublancin_3 # 857 # 1855 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.395	BGC0000558.1|Sublancin_3 	857	1855	+	Loose	175	28.1054	vanT gene in vanG cluster	28.85	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGATTGATTACTCACAATTTCCACGTAAGAATATACTTTGTGTCGATATGAAATCCTTTTATGCTTCTGTATCGGCTGTAACAATGGGGCTTAACCCTTTAACATGCTATCTTGCTGTTGTAGGGAATACGGAGAGACAGGGAAGTGTAGTATTAGCTGCATCTCCTGCACTTAAAAAAGATTTTGGAATCAAAACAGGATCGAGACTATTTGAGATACCTGAAGATCCAAGGATACACATTGTAAATCCACAAATGAAGCTTTTCATCAGAGTTTCAACTGAAATTACAAAGCTGTTTTACAGATTTGTTCCTGAGAAATGTGTCCATACGTATTCAATTGATGAATCTTTTTTAGATGCAGGAAAAGAAGATCCTGAAGAAATGGCCAAAGCAATCCAAAGCAGCATGTGGAGAGAATTTGGTTTGATGTGCACAGTTGGTATTGGAGACAATATGCTACTCAGTAAGCTTGCACTTGACCTGGAGAGTAAGAAAACAAAGAGTGGCATTGCACGTTGGAGATATGAAGATGTACCAAATAAACTCTGGAAGGTTCGCCCTTTGTCTAAAATGTGGGGGATAGGAGGGAGGATGGAAAGAAACCTAAATCGGATGGGAATATCGACTATAGGTCAGTTAGCCAAATTTCCTTTAGAGCTGCTTGAAAAGAAGTTCGGAATAATGGGAAACCAGTTGTACTACCATGCTCACGGAATTGATTTATCAGAAATAGGTGCTCCGTTGATGCAAGGTCAGATTAGTTTCGGTAAGAGTCAGATTTTACTGAGGGATTACACAAGGAGTGAAGAGATTAAGGCGGTTCTTCTGGAGATTTGTGAAGAAGTCGCAAGAAGGCACGTACACATAATAAAGTTGGTCGAACAATCAGTCTGGGAATTGGGTACAGTAAGGATGAGCTTGGTGGTGGTTTTCATCGTTCCAAAACAATTGATCTTCCTACAAGTATCACGATGGATATTTATAGATGCTGCTTGA	MIDYSQFPRKNILCVDMKSFYASVSAVTMGLNPLTCYLAVVGNTERQGSVVLAASPALKKDFGIKTGSRLFEIPEDPRIHIVNPQMKLFIRVSTEITKLFYRFVPEKCVHTYSIDESFLDAGKEDPEEMAKAIQSSMWREFGLMCTVGIGDNMLLSKLALDLESKKTKSGIARWRYEDVPNKLWKVRPLSKMWGIGGRMERNLNRMGISTIGQLAKFPLELLEKKFGIMGNQLYYHAHGIDLSEIGAPLMQGQISFGKSQILLRDYTRSEEIKAVLLEICEEVARRHVHIIKLVEQSVWELGTVRMSLVVVFIVPKQLIFLQVSRWIFIDAA	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	46.63	gnl|BL_ORD_ID|1522|hsp_num:0	1561			969	1125	vancomycin
BGC0000558.1|Sublancin_4 # 1855 # 2106 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.389	BGC0000558.1|Sublancin_4 	1855	2106	+	Loose	600	23.0978	CBP-1	23.08	3004764	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CBP beta-lactamase	ATGCTTTTTAATAAGTTTTACTCGGGTAAGACTGTGAGAAGTGTCTCAGTCACGTTATCGAATATTGAGGATGATGTTAATCAGCAGCTGAGTTTATTTGAAGTGGATAATGAAAAGAGAAGGAAACTCGGTTTTGTAATGGATGGGATTAGAAGTAAATACGGCTCTAAAGCGATTCTGAGAGCAGTTTCTTATACACCAGCAGGAACTGCACTTCAACGAGCTGGATTAACAGGTGGGCATAAGAGTTAA	MLFNKFYSGKTVRSVSVTLSNIEDDVNQQLSLFEVDNEKRRKLGFVMDGIRSKYGSKAILRAVSYTPAGTALQRAGLTGGHKS	MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGVKLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSYAPVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARIEPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGAPKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFIAILSSKNDKDAKYDDKTISEASKIVFDYFINTRK	26.95	gnl|BL_ORD_ID|2517|hsp_num:0	3567			150	381	
BGC0000558.1|Sublancin_5 # 2208 # 2525 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.261	BGC0000558.1|Sublancin_5 	2208	2525	+	Loose	575	24.6386	MBL1b	25.0	3006951	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MBL beta-lactamase	ATGGAATATGTAGTTATGATAATCATTTTATTAGCACTTTTCTTTATTTTTACTGTTTTCCTAAATACACGTTATAGTTTTGATGAAAAATGCTTAGTCTTAAAATTTGGTTTATCTAAAACAGAAATTCCAATTAATCAAATAGTTAGTATTAAAGAGTCAGACAAGTATGGAGTTGCAGATAATATCGATTATAAAATTGGTATGCCATATGCTCAACCAGATAGAATTGTTATTGAAACTACAAATAAGCGTTTTCTAGTTTTTTTAAATGGAGCTCAACAATTTATTCAAAAGTATAAAAGGGTTAGTGTTTGA	MEYVVMIIILLALFFIFTVFLNTRYSFDEKCLVLKFGLSKTEIPINQIVSIKESDKYGVADNIDYKIGMPYAQPDRIVIETTNKRFLVFLNGAQQFIQKYKRVSV	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLHGGPNAETGKLVERNITALGFQLADLKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPKP	36.33	gnl|BL_ORD_ID|3692|hsp_num:0	4762			270	447	
BGC0000558.1|Sublancin_6 # 2822 # 2992 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.421	BGC0000558.1|Sublancin_6 	2822	2992	+	Loose	500	22.3274	bacA	26.19	3002986	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	undecaprenyl pyrophosphate related proteins	ATGGAAAAGCTATTTAAAGAAGTTAAACTAGAGGAACTCGAAAACCAAAAAGGTAGTGGATTAGGAAAAGCTCAGTGTGCTGCGTTGTGGCTACAATGTGCTAGTGGCGGTACAATTGGTTGTGGTGGCGGAGCTGTTGCTTGTCAAAACTATCGTCAATTCTGCAGATAA	MEKLFKEVKLEELENQKGSGLGKAQCAALWLQCASGGTIGCGGGAVACQNYRQFCR	MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVMFWRRLFGLIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGGLLLIAAECLKPKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPMMMGATALDLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF	20.51	gnl|BL_ORD_ID|1681|hsp_num:0	1820			444	570	bacitracin; bacitracin A; bacitracin B; bacitracin F
BGC0000558.1|Sublancin_7 # 3050 # 5167 # 1 # ID=1_7;partial=00;start_type=TTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.288	BGC0000558.1|Sublancin_7 	3050	5167	+	Loose	1000	157.918	msbA	24.54	3003950	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGAATAAGAAAAAGAAATATGTTCATACTAAACAGTTTAATAGTCATGATTGTGGACTAGCTTGTATCTCGTCAATTTTAAAGTTTCATAACCTTAACTATGGAATTGATTTCTTACTAGACCTAATTGGGGATAAGGAAGGCTATAGTTTAAGAGACTTAATTGTTATTTTTAAGAAGATGGGGATAAAAACTAGGCCACTTGAATTGCAAGAAAATAAGACATTCGAAGCCCTAAAACAAATAAAGCTCCCTTGTATAGCTTTGTTAGAAGGGGAGGAATATGGACATTACATAACAATATACGAAATTAGAAATAACTATTTACTTGTTAGTGATCCTGATAAAGACAAAATAACTAAAATAAAAAAAGAGGATTTTGAAAGTAAATTCACAAACTTTATATTAGAAATTGACAAAGAGTCAATTCCTGAAAAAGAAAAAGATCAAAAAAAACATTCTTACTTTTTTAAGGACATACTTTTTAGAAATAAATTGATCGTTTTTGTGATTTTATTGACTTCCTTGTTCGTTGTGGGTCTTGCTGTAGCTGGGTCGTTTTATATAAAGTTTCTAGTTGACCTAATTATCCCAAGAAGCTTAAGAGAATCTTTAATCACAATCACTTTAATATTCATAAGTATGGTCTTAATAAGGTGCATCTTCGATTTTGTAAGATCATATTTGATAATAAAATTGTCTTACAAAGTTGATAAAGAGATGTCAAATGTTTATTTTAATAAAGTAACAAAATTACCTATTAATTTTTTTGAAAACAGAGAAGATGGAGAGGTAATTTCTCGATTCAATGATGGTATATATATTAAAGACTTTTTTAGTGCTAACTTTGTTACTGCAATAATTGATATAATTTTAATACTGGGATTAGGAGTTATTTTATATAGAACAAATAACATTCTTTTCTTAACAATTATTCTCCCGATTTTGCTACTTTCATGTCTAGCGATTTTGTTTTTTGATCATCTTAAAAAGAAAAATCAAAAACTGATGGAGGATAAGGCTAAATCTACCTCTCTTTTAATTAATTTTCTGAAGAATATGACAACTGTTTATTCTTTAAATAAAACCTCGTTTTTTTTAGAAAAATTTCATCTTACATATGATAAACAATTAAATTCAACCTTTAGTGTAGCAAAGGCAGTTATTAGCAATGAAATACTAAAAGGATTAATTCAAAACTCTTTTACAATAATTATCCTATGGGTTGGGACAAGACAAGTTCTAAATGATTCAATGAGTTTGGGTACACTGCTATTTATAAACACATTAGCAGCCTTTTTGCTAAGTTCACTAGATCGTATATTGAGTATGCAATCAGATCTTCAGCAGGCACATGTTGCTTCCATAAGATTTTTTGACGTAGTAAACTATCCAGTTCAGCAAGATAGCAATGAGAATTTAACTGAACTTGATTTTATTCAGAATATCAAAACAGTTAATCTTAATATTGGGGCAGACCCAATGCGTTATATAGTTGAAGATATTAATTTAATATTAGACAGAAAGGATAAAGTCCTTATTATTGGAGAAAGTGGTACTGGAAAAAGTACGTTTGCAAAAAGTTTGTCTAAATTGTATAAAGTACCCGATAAGTCAATTTATTTAAATGGATTAGATATTAATCGATACGATCATTTATCAATAAGAAAAAGGATTGTATATATTGACGAAAATCCTTTTCTTTTTAAGGGAACCATTAAAGAGAATCTTTGCATGGGAGAGATTTTTGATCAGAACGAAATTGAAAACGCGTGTATAATGTCCCAATGCCATGAATTCATTTGTAACTTGGACAAGCAGTACAGTTATAAATTGTCTGAAAACGGTTCCAATCTATCTACAGGACAAAAACAACGGTTAGCATTAGCAAGAGCAATTTTACATCAACCACAAGTATTAATTTTAGATGAGTCATTATCTAACATTGATCCGGATAACACAAAATTGATTTATGAAACCTTACACAGGATGGATTGTTTAATTATTCTTATAACTCATAATGACCCAAGTAACTTCAAATACAATAAAAAATTAGTATTCAGAAACAATAGGATTATAGAGTCGAGCTACTCGGAAAATAAGGAGTATTCTATATGA	MNKKKKYVHTKQFNSHDCGLACISSILKFHNLNYGIDFLLDLIGDKEGYSLRDLIVIFKKMGIKTRPLELQENKTFEALKQIKLPCIALLEGEEYGHYITIYEIRNNYLLVSDPDKDKITKIKKEDFESKFTNFILEIDKESIPEKEKDQKKHSYFFKDILFRNKLIVFVILLTSLFVVGLAVAGSFYIKFLVDLIIPRSLRESLITITLIFISMVLIRCIFDFVRSYLIIKLSYKVDKEMSNVYFNKVTKLPINFFENREDGEVISRFNDGIYIKDFFSANFVTAIIDIILILGLGVILYRTNNILFLTIILPILLLSCLAILFFDHLKKKNQKLMEDKAKSTSLLINFLKNMTTVYSLNKTSFFLEKFHLTYDKQLNSTFSVAKAVISNEILKGLIQNSFTIIILWVGTRQVLNDSMSLGTLLFINTLAAFLLSSLDRILSMQSDLQQAHVASIRFFDVVNYPVQQDSNENLTELDFIQNIKTVNLNIGADPMRYIVEDINLILDRKDKVLIIGESGTGKSTFAKSLSKLYKVPDKSIYLNGLDINRYDHLSIRKRIVYIDENPFLFKGTIKENLCMGEIFDQNEIENACIMSQCHEFICNLDKQYSYKLSENGSNLSTGQKQRLALARAILHQPQVLILDESLSNIDPDNTKLIYETLHRMDCLIILITHNDPSNFKYNKKLVFRNNRIIESSYSENKEYSI	MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTDRSVLVWMPLVVIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITYDSEQVASSSSGALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTMGQVTTSAEQMLKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAASFPSVMDSLTAGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATGDVEFRNVTFTYPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREYTLASLRNQVALVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVLLSGGQRQRIAIARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVVVEDGVIVERGTHNDLLEHRGVYAQLHKMQFGQ	121.13	gnl|BL_ORD_ID|2185|hsp_num:0	2423			66	1674	metronidazole
